Cover Image
市場調查報告書

呼吸系統疾病用醫藥品:抗氣喘藥·COPD藥·止咳藥&感冒藥

Respiratory Diseases Drugs Global Market Report 2018

出版商 The Business Research Company 商品編碼 531335
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
呼吸系統疾病用醫藥品:抗氣喘藥·COPD藥·止咳藥&感冒藥 Respiratory Diseases Drugs Global Market Report 2018
出版日期: 2018年02月01日 內容資訊: 英文 125 Pages
簡介

本報告提供全球呼吸系統疾病用醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物/疾病部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 呼吸系統疾病用醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 抗氣喘藥·COPD藥
    • 止咳藥·感冒藥
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 呼吸系統疾病用醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 氣喘的患病人數:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • GlaxoSmithKline
  • Novartis Ag
  • Pfizer Inc.
  • Boehringer Ingelheim
  • Astrazeneca Plc

第18章 主要M&A:呼吸系統疾病用醫藥品市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Respiratory Diseases Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global respiratory diseases drugs market.

Where is the largest and fastest growing market for the respiratory diseases drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory diseases drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.

Scope:

Markets Covered: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

Companies Mentioned: GlaxosmithKline Plc,AstraZeneca Plc,Merck & Co,Novartis AG,Johnson & Johnson

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

1. Respiratory Diseases Drugs Market Characteristics

2. Respiratory Diseases Drugs Market Size And Growth

  • 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth, Value ($ Billion)
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Respiratory Diseases Drugs Trends And Strategies

4. Pestle Analysis

  • 4.1. Political
  • 4.2. Economic
  • 4.3. Social
  • 4.4. Technological
  • 4.5. Legal
  • 4.6. Environmental

5. Respiratory Diseases Drugs Market Customer Information

6. Respiratory Diseases Drugs Market Regional And Country Analysis

  • 6.1. Global Respiratory Diseases Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  • 6.2. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  • 6.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region
  • 6.4. Global Respiratory Diseases Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  • 6.5. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  • 6.6. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Country

7. Respiratory Diseases Drugs Market Segmentation

  • 7.1. Global Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

  • 7.2. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. Respiratory Diseases Drugs Market Segments

  • 8.1.Anti-Asthmatics And COPD Drugs

a) Market Characteristics

b) Market Trends & Strategies

c) Global Anti-Asthmatics And COPD Drugs Market, 2017, By Segment, Value ($ Billion)

  • 8.2.Cough And Cold Preparations

a) Market Characteristics

b) Market Trends & Strategies

c) Global Cough And Cold Preparations Market, 2017, By Segment, Value ($ Billion)

9. Global Respiratory Diseases Drugs Market Comparison With Macro Economic Factors

  • 9.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, Global
  • 9.2. Per Capita Average Respiratory Diseases Drugs Expenditure, Global

10. Respiratory Diseases Drugs Market Comparison With Macro Economic Factors Across Countries

  • 10.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, By Country
  • 10.2. Per Capita Average Respiratory Diseases Drugs Expenditure, By Country

11. Respiratory Diseases Drugs Market Comparison With Industry Metrics

  • 11.1. Global Number Of Pharmacists, 2017, By Country
  • 11.2. Global Respiratory Diseases Market Revenue Versus Number Of Pharmacists, 2017, By Country
  • 11.3. Global Number Of Pharma Enterprises, 2017, By Country
  • 11.4. Global Respiratory Diseases Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
  • 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
  • 11.6. Global Respiratory Diseases Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
  • 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.8. Global Respiratory Diseases Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.9. Prevalent Cases of Asthma, 2014, By Country
  • 11.10. Global Number Of General Practitioners 2017, By Country
  • 11.11. Global Respiratory Diseases Market Revenue Versus Number Of General Practitioners, 2017, By Country

12. Asia-Pacific Respiratory Diseases Drugs Market

    • 12.1.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
    • 12.1.2. Asia-Pacific Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.1.3. Asia-Pacific Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.1.4. Asia-Pacific Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.1.5. Asia-Pacific Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.2. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
  • 12.3. China Respiratory Diseases Drugs Market
    • 12.3.1. China Respiratory Diseases Drugs Market Overview
    • 12.3.2. China Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.3.3. China Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.3.4. China Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.3.5. China Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.4. India Respiratory Diseases Drugs Market
    • 12.4.1. India Respiratory Diseases Drugs Market Overview
    • 12.4.2. India Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.4.3. India Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.4.4. India Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.4.5. India Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.5. Japan Respiratory Diseases Drugs Market
    • 12.5.1. Japan Respiratory Diseases Drugs Market Overview
    • 12.5.2. Japan Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.5.3. Japan Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.5.4. Japan Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.5.5. Japan Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.6. Australia Respiratory Diseases Drugs Market
    • 12.6.1. Australia Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.6.2. Australia Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.6.3. Australia Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.6.4. Australia Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. Western Europe Respiratory Diseases Drugs Market

    • 13.1.1. Western Europe Respiratory Diseases Drugs Market Overview
    • 13.1.2. Western Europe Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.1.3. Western Europe Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.1.4. Western Europe Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.1.5. Western Europe Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.2. Western Europe Respiratory Diseases Drugs Market: Country Analysis
  • 13.3. UK Respiratory Diseases Drugs Market
    • 13.3.1. UK Respiratory Diseases Drugs Market Overview
    • 13.3.2. UK Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.3.3. UK Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.3.4. UK Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.3.5. UK Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.4. Germany Respiratory Diseases Drugs Market
    • 13.4.1. Germany Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.4.2. Germany Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.4.3. Germany Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.4.4. Germany Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.5 France Respiratory Diseases Drugs Market
    • 13.5.1 France Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.5.2 France Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.5.3. France Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.5.4. France Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.6. Italy Respiratory Diseases Drugs Market
    • 13.6.1. Italy Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.6.2. Italy Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.6.3. Italy Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.6.4. Italy Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.7. Spain Respiratory Diseases Drugs Market
    • 13.7.1. Spain Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.7.2. Spain Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.7.3. Spain Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.7.4. Spain Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Respiratory Diseases Drugs Market

    • 14.1.1. Eastern Europe Respiratory Diseases Drugs Market Overview
    • 14.1.2. Eastern Europe Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.1.3. Eastern Europe Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.1.4. Eastern Europe Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 14.1.5. Eastern Europe Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 14.2. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
  • 14.3. Russia Respiratory Diseases Drugs Market
    • 14.3.1. Russia Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.3.2. Russia Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.3.3. Russia Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 14.3.4. Russia Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. North America Respiratory Diseases Drugs Market

    • 15.1.1. North America Respiratory Diseases Drugs Market Overview
    • 15.1.2. North America Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.1.3. North America Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.1.4. North America Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 15.1.5. North America Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 15.2. North America Respiratory Diseases Drugs Market: Country Analysis
  • 15.3. USA Respiratory Diseases Drugs Market
    • 15.3.1. USA Respiratory Diseases Drugs Market Overview
    • 15.3.2. USA Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.3.3. USA Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.3.4. USA Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 15.3.5. USA Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. South America Respiratory Diseases Drugs Market

    • 16.1.1. South America Respiratory Diseases Drugs Market Overview
    • 16.1.2. South America Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.1.3. South America Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.1.4. South America Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 16.1.5. South America Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 16.2. South America Respiratory Diseases Drugs Market: Country Analysis
  • 16.3. Brazil Respiratory Diseases Drugs Market
    • 16.3.1. Brazil Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.3.2. Brazil Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.3.3. Brazil Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 16.3.4. Brazil Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. Middle East Respiratory Diseases Drugs Market

    • 17.1.1. Middle East Respiratory Diseases Drugs Market Overview
    • 17.1.2. Middle East Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 17.1.3. Middle East Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 17.1.4. Middle East Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 17.1.5. Middle East Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. Africa Respiratory Diseases Drugs Market

    • 18.1.1. Africa Respiratory Diseases Drugs Market Overview
    • 18.1.2. Africa Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 18.1.3. Africa Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 18.1.4. Africa Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 18.1.5. Africa Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. Respiratory Diseases Drugs Market Competitive Landscape

  • 19.1. Company Profiles
  • 19.2. GlaxosmithKline Plc
    • 19.2.1. Overview
    • 19.2.2. Products And Services
    • 19.2.3. Strategy
    • 19.2.4. Financial Performance
  • 19.3. AstraZeneca Plc
    • 19.3.1. Overview
    • 19.3.2. Products And Services
    • 19.3.3. Strategy
    • 19.3.4. Financial Performance
  • 19.4. Merck & Co
    • 19.4.1. Overview
    • 19.4.2. Products And Services
    • 19.4.3. Strategy
    • 19.4.4. Financial Performance
  • 19.5. Novartis AG
    • 19.5.1. Overview
    • 19.5.2. Products And Services
    • 19.5.3. Strategy
    • 19.5.4. Financial Performance
  • 19.6. Johnson & Johnson
    • 19.6.1. Overview
    • 19.6.2. Products And Services
    • 19.6.3. Strategy
    • 19.6.4. Financial Performance

20. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

21. Market Background: Respiratory Diseases Drugs Market

    • 21.1.1. Respiratory Diseases Drugs Market Characteristics
    • 21.1.2. Respiratory Diseases Drugs Market Historic Growth, Value ($ Billion)
      • 21.1.2.1. Drivers Of The Market
      • 21.1.2.2. Restraints Of The Market
    • 21.1.3. Respiratory Diseases Drugs Market Forecast Growth, Value ($ Billion)
      • 21.1.3.1. Drivers Of The Market
      • 21.1.3.2. Restraints Of The Market
    • 21.1.4. Respiratory Diseases Drugs Trends And Strategies
  • 21.2. Respiratory Diseases Drugs Market Regional And Country Analysis
    • 21.2.1. Global Respiratory Diseases Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
    • 21.2.2. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Region
    • 21.2.3. Respiratory Diseases Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
    • 21.2.4. Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Country
    • 21.2.5. Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Segment
    • 21.2.6. Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Country And Segment
  • 21.3. Global Respiratory Diseases Drugs Market Comparison With Macro Economic Factors
    • 21.3.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, Global
    • 21.3.2. Per Capita Average Respiratory Diseases Drugs Expenditure, Global
  • 21.4. Respiratory Diseases Drugs Market Comparison With Macro Economic Factors Across Countries
    • 21.4.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, By Country
    • 21.4.2. Per Capita Average Respiratory Diseases Drugs Expenditure, By Country
  • 21.5. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

22. Appendix

  • 22.1. NAICS Definitions Of Industry Covered In This Report
  • 22.2. Abbreviations
  • 22.3. Currencies
  • 22.4. Research Inquiries
  • 22.5. The Business Research Company
  • 22.6. Copyright And Disclaimer
Back to Top